<DOC>
	<DOCNO>NCT02036645</DOCNO>
	<brief_summary>The purpose study assess safety , drug level effect body 1 3 injection MEDI1814 , people mild moderate Alzhiemer 's Disease healthy elderly people .</brief_summary>
	<brief_title>SAD/MAD Study Assess Safety , Tolerability , PK &amp; PD MEDI1814 Subjects With Mild-Moderate Alzheimer 's Disease .</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Inclusion Criteria Male female ( non child bear potential ) subject Mildmoderate Alzheimer 's Disease Exclusion Criteria History evidence significant autoimmune disease Presence psychiatric disorder would affect completion study Current serious unstable clinically important illness</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>